382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma
Espen B. Ellingsen(Oslo University Hospital), Gustav Gaudernack(Oslo University Hospital), Sara M. Mangsbo(Uppsala University), Iliana Kerzeli(Uppsala University), Else-Marit Inderberg-Suso(Oslo University Hospital), Irantzu Anzar(Oslo Cancer Cluster), Steinar Aamdal(Humboldt-Universität zu Berlin), Tormod Kyrre Guren(Oslo University Hospital), Nadia Mensali(Oslo University Hospital), Eivind Hovig(Oslo University Hospital), Trevor Clancy(Inholland University of Applied Sciences), Elin Aamdal(Oslo University Hospital)
Cited by 0
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
|Nature Communications|2015|337
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
|The Journal of Cell Biology|2010|165